Joint Pain

SAN DIEGO — Contrary to previous findings, the risk for psoriatic arthritis was persistent among patients with psoriasis and did not wane over time, according to a presentation at the 2019 Congress of Clinical Rheumatology West.

Healio spoke with two clinicians from Johns Hopkins University about the psoriatic arthritis treatment landscape, specifically touching on JAK inhibitor and interleukin-6 agents.